Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add filters








Type of study
Language
Year range
1.
Journal of Chongqing Medical University ; (12)2003.
Article in Chinese | WPRIM | ID: wpr-576822

ABSTRACT

Objective:To present the experience in diagnosis and treatment on newborn's incarcerated hernia.Methods:The clinical data of 34 cases of newborn's incarcerated hernia was analysed from 1999 to 2006.Results:32 cases of newborn's incarcerated hernia were treated by operation with 8 cases in intestinal necrosis and 5 cases in spermary necrosis.2 cases were treated by hands.There are 8 cases with complications and 2 dead cases post-operation.The cure rate of operation,complication rate and mortality were 94.11%,22.52% and 5.88%respectively.Conclusions:The early diagnosis and operation treatment is value for newborn's incarcerated hernia.Nutritional supportive treatment and preventing toxic shock are elevation curative effect criticality.

2.
Journal of Chongqing Medical University ; (12)2003.
Article in Chinese | WPRIM | ID: wpr-576153

ABSTRACT

Objective:To observe and summarize the therapeutic effects of intratumoral injection with Triamcinolone Acetonide Acetate and Pingyangmycin on infant maxillofacial hemangioma.Methods:Local injection with Triamcinolone Acetonide Acetate(TAA)and Pingyangmycin(PYM)was executed to treat infant maxillofacial hemangioma.If the lesion did not disappear,the treatment would be performed again every four to six weeks at intervals,and the total dose of TAA and PYM could not be more than 100mg and 40mg respectively.The injection treatment was repeated 4 times for one course and the therapeutic effects of maxillofacial hemangioma were detected.Results: 84 cases with maxillofacial hemangioma,treated by local injection with TAA and PYM,had been followed up for one to three years.The cure rate was 90.4%,the notable rate was 7.1%,and the ineffective rate was 2.4%.Conclusions:The intratumoral injection with Triamcinolone Acetonide Acetate and Pingyangmycin is the reliable therapy method with less side effects.It is valuable for treatment of infant maxillofacial hemangioma.

3.
Journal of Third Military Medical University ; (24)2003.
Article in Chinese | WPRIM | ID: wpr-560268

ABSTRACT

Objective To report 44 cases of meta-superior position anorectal malformation in different age therapied by posterior sagittal anorectoplasty(PSARP) operation, and to discuss possibility of one-stage anorectoplasty via posterior sagittal approach in neonate. Methods The clinical data of 44 cases meta-superior position anorectal malformation,which were treated by PSARP,were studied retrospectively. Results Of 44 cases, 15 were treated by colon stoma in neonate, then PSARP was executed after 3~7 months. And the rest 29 cases (9 in neonate and 20 in 2 months~9 years) were operated with one-stage anorectoplasty via posterior sagittal approach. Among 21 children followed from post-operration 6 months to 5 years, 18 cases of defecation clinical score were fineness. Conclusion The curative effects of PSARP in neonate to meta-superior position anorectal malformation is satisfactory. If the neonate is in good condition, one-stage anorectoplasty via posterior sagittal approach could be executed in infant, and favourable defecate function could be remain.

4.
Journal of Third Military Medical University ; (24)1984.
Article in Chinese | WPRIM | ID: wpr-560848

ABSTRACT

Objective To investigate the effects and complications of injection with triamcinolone acetonide acetate and Pingyangmycin on maxillofacial and perineal hemangioma. Methods Local injection with triamcinolone acetonide acetate (TAA) and Pingyangmycin (PYM) was performed to treat infant maxillofacial and perineal hemangiomas: strawberry hemangioma, cavernous hemangioma and mixed hemangioma, in 107 infants admitted to our hospital from 1996 to 2005. If the lesion did not disappear after the first treatment, the injection would be performed again every four to six weeks interval, and the total dose of TAA and PYM could not be more than 100 mg and 40 mg respectively. The injection treatment was repeated 4 times for one course and the therapeutic effects on maxillofacial and perineal hemangioma was evaluated. Results All cases were followed up for one year after local injection of TAA and PYM. The cure rate was 87.8%, the effective rate was 9.3%, and the ineffective rate was 2.8%. Conclusion The injection of TAA and PYM is a reliable and less side effect therapeutic method, and valuable for infant maxillofacial and perineal hemangioma.

SELECTION OF CITATIONS
SEARCH DETAIL